State of Wyoming’s Sage Therapeutics SAGE Stock Holding History

State of Wyoming’s Portfolio SAGE Stock Details SAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-25,449	Closed	-$202K	–	2074
2025 Q1	$202K	Buy	+25,449	New	+$186K	0.03%	795
2022 Q2	–	Sell	-2,809	Closed	-$93K	–	2102
2022 Q1	$93K	Sell	2,809 -294	-9%	-$11.1K	0.05%	658
2021 Q4	$132K	Buy	3,103 +1,641	+112%	+$68.7K	0.06%	443
2021 Q3	$65K	Sell	1,462 -2,973	-67%	-$136K	0.04%	660
2021 Q2	$252K	Buy	+4,435	New	+$314K	0.16%	127

Other funds holding SAGE

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

State of Wyoming's SAGE Position: Q2 2025 in Review

State of Wyoming sold out of Sage Therapeutics (SAGE) in Q2 2025, closing a stake of 25,449 shares — an estimated $202K sold.

State of Wyoming first reported a position in SAGE in Q2 2021 and held it in 5 quarters. The position peaked at $252K in Q2 2021. 191 funds tracked by Wall St. Rank hold SAGE as of Q2 2025.

State of Wyoming reported no remaining Sage Therapeutics position as of Q2 2025 after selling out during the quarter.
State of Wyoming sold 25,449 Sage Therapeutics shares in Q2 2025, an estimated $202K.
State of Wyoming first reported a position in Sage Therapeutics in Q2 2021 and held it in 5 quarters.
State of Wyoming's Sage Therapeutics position peaked at $252K in Q2 2021.
191 funds tracked by Wall St. Rank held Sage Therapeutics as of Q2 2025.

Based on State of Wyoming's 13F filing for Q2 2025, filed 19 Aug 2025.